Showing results (21-30 of 498) with videos related to
Sort By:
Pageof 50
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2021
Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunityCristiane Sécca, Jennifer K Bando, José L Fachi, et al.Nature Immunology|August 1, 2017
SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signalingVictor S Cortez, Tyler K Ulland, Luisa Cervantes-Barragan, et al.The Journal of Infectious Diseases|June 7, 2003
TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responsesMarco Colonna, Fabio FacchettiMed (New York, N.Y.)|June 30, 2021
Turning enemies into allies-reprogramming tumor-associated macrophages for cancer therapyMartina Molgora, Marco ColonnaThe Journal of Experimental Medicine|July 22, 2021
Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice?Yun Chen, Marco ColonnaImmunological Reviews|March 3, 2010
Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and toleranceMelissa Swiecki, Marco ColonnaJournal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cgamma signaling pathways in human NK cellsIlaria Tassi, Marco ColonnaTrends in Pharmacological Sciences|December 12, 2018
The CNS Immune-Privilege Goes Down the Drain(age)Simone Brioschi, Marco ColonnaCurrent Opinion in Gastroenterology|October 9, 2013
Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tractAnja Fuchs, Marco ColonnaNeuron|January 22, 2026
The TREM2 T96K paradox: Stronger signaling in vitro, weaker microglia in vivoSilvia Penati, Marco ColonnaPageof 50